CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q321 Q421 Q122 Q222 Q322 Q422 Q123 Q223 Q323 Revenues: Clearing and transaction fees 878.9 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 Market data and information services 145.4 142.1 151.7 151.7 154.3 153.2 165.8 163.1 167.6 Other Revenue 85.6 55.9 56.8 60.9 74.9 73.2 75.6 78.8 84.7 Total revenues 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 Expenses: Compensation and benefits 198.6 201.7 185.2 185.3 189.6 193.0 204.5 205.7 205.5 Technology 49.3 45.8 45.9 45.9 46.8 50.0 51.3 53.3 55.6 Professional fees and outside services 45.2 32.3 31.8 32.0 35.1 38.5 38.3 37.8 32.2 Amortization of purchased intangibles 59.0 58.6 58.4 57.1 55.5 56.7 56.8 57.0 57.2 Depreciation and amortization 37.2 35.9 33.5 33.0 34.5 33.9 31.9 32.3 31.1 Licensing and other fee agreements 57.6 60.4 80.9 83.1 83.6 72.4 84.7 78.2 79.5 Other expense 49.3 80.9 51.8 51.1 43.9 95.0 60.4 57.3 56.5 Operating expenses 496.2 515.6 487.5 487.5 489.0 539.5 527.9 521.6 517.6 Operating Income 613.7 631.7 859.1 749.7 738.8 668.3 913.7 838.6 820.2 Operating Margin 55% 55% 64% 61% 60% 55% 63% 62% 61% Non-operating Income and Expense Investment income 145.8 67.8 73.1 286.9 686.2 1,152.2 1,357.7 1,568.2 1,272.5 Interest and other borrowing costs (41.8) (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) Equity in net gains (losses) of unconsolidated subsidiaries 66.4 67.5 73.3 87.3 76.5 64.0 78.2 75.1 76.8 Other non-operating income (expense) 311.8 74.2 (46.7) (217.3) (581.1) (1,017.3) (1,152.8) (1,425.3) (1,155.6) Non-operating income (expense) 482.2 167.6 57.2 117.0 141.2 159.0 243.2 177.8 154.1 Income before income taxes 1,095.9 799.3 916.3 866.7 880.0 827.3 1,156.9 1,016.4 974.3 Income taxes 169.6 174.1 205.3 204.2 200.4 189.4 273.1 238.8 224.1 Net income 926.3 625.2 711.0 662.5 679.6 637.9 883.8 777.6 750.2 Less: net income (loss) attributable to NCI (0.2) - - - - - - - - Net Income Attributable to CME Group 926.5 625.2 711.0 662.5 679.6 637.9 883.8 777.6 750.2 Net Income Attributable to Common Shareholders of CME Group 926.5 613.3 702.0 654.1 671.1 629.9 872.7 767.8 740.8 Effective Tax Rate 15.5% 21.8% 22.4% 23.6% 22.8% 22.8% 23.6% 23.5% 23.0% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.59 1.71 1.96 1.82 1.87 1.76 2.43 2.14 2.06 Diluted EPS 2.58 1.71 1.95 1.82 1.87 1.75 2.43 2.14 2.06 Weighted average number of common stock shares: Basic Shares 358,363 358,582 358,609 358,641 358,715 358,885 358,933 358,940 359,020 Diluted Shares 358,988 359,019 359,180 359,205 359,288 359,190 359,313 359,429 359,619 Preferred Shares 2,890 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q321 Q421 Q122 Q222 Q322 Q422 Q123 Q223 Q323 Revenues: Clearing and transaction fees 878.9 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 Market data and information services 145.4 142.1 151.7 151.7 154.3 153.2 165.8 163.1 167.6 Other Revenue 85.6 55.9 56.8 60.9 74.9 73.2 75.6 78.8 84.7 Total revenues 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 Expenses: Compensation and benefits 191.1 183.7 182.8 189.5 189.1 184.6 192.8 194.4 193.5 Technology 49.1 45.6 45.8 45.9 46.8 50.0 51.3 53.3 55.6 Professional fees and outside services 26.5 27.2 30.3 31.4 35.1 38.5 38.3 37.8 32.2 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 36.7 35.6 33.5 32.9 33.8 33.9 31.9 31.8 31.1 Licensing and other fee agreements 57.6 60.4 80.9 83.1 81.9 72.4 84.7 78.2 79.5 Other expense 51.3 76.5 51.7 59.6 54.4 84.5 59.7 56.2 56.5 Operating expenses 412.3 429.0 425.0 442.4 441.1 463.9 458.7 451.7 448.4 Operating Income 697.6 718.3 921.6 794.8 786.7 743.9 982.9 908.5 889.4 Operating Margin 63% 63% 68% 64% 64% 62% 68% 67% 66% Non-operating Income and Expense Investment income 55.1 58.2 74.7 299.5 688.5 1,147.1 1,277.5 1,564.0 1,276.6 Interest and other borrowing costs (41.8) (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) Equity in net gains (losses) of unconsolidated subsidiaries 70.5 78.7 84.7 98.2 89.6 76.2 91.5 88.6 90.4 Other non-operating income (expense) (32.9) (33.0) (43.4) (218.5) (585.7) (1,023.3) (1,160.6) (1,429.9) (1,157.1) Non-operating income (expense) 50.9 62.0 73.5 139.3 152.0 160.1 168.5 182.5 170.3 Income before income taxes 748.5 780.3 995.1 934.1 938.7 904.0 1,151.4 1,091.0 1,059.7 Income taxes 174.3 172.8 228.9 217.6 219.6 206.0 269.1 254.6 241.7 Net income 574.2 607.5 766.2 716.5 719.1 698.0 882.3 836.4 818.0 Less: net income (loss) attributable to NCI (0.2) - - - - - - - - Net Income Attributable to CME Group 574.4 607.5 766.2 716.5 719.1 698.0 882.3 836.4 818.0 Net Income Attributable to Common Shareholders of CME Group 574.4 595.7 756.6 707.5 710.0 689.1 871.1 825.9 807.9 Effective Tax Rate 23.3% 22.1% 23.0% 23.3% 23.4% 22.8% 23.4% 23.3% 22.8% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.60 1.66 2.11 1.97 1.98 1.92 2.43 2.30 2.25 Diluted EPS 1.60 1.66 2.11 1.97 1.98 1.92 2.42 2.30 2.25 Weighted average number of common stock shares: Basic Shares 358,363 358,582 358,609 358,641 358,715 358,885 358,933 358,940 359,020 Diluted Shares 358,988 359,019 359,180 359,205 359,288 359,190 359,313 359,429 359,619 Preferred Shares - 2,890 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --